Efficacy of DL-alpha-difluoromethylornithine in a rat model of Pneumocystis carinii pneumonia
about
Treatment of experimental pneumocystosis: review of 7 years of experience and development of a new system for classifying antimicrobial drugsDeferoxamine and eflornithine (DL-alpha-difluoromethylornithine) in a rat model of Pneumocystis carinii pneumoniaEffect of a bis-benzyl polyamine analogue on Pneumocystis cariniiAction of deferoxamine against Pneumocystis cariniiPolyamine content of Pneumocystis carinii and response to the ornithine decarboxylase inhibitor DL-alpha-difluoromethylornithineMechanism and tissue specificity of nicotine-mediated lung S-adenosylmethionine reduction.A cytotoxicity assay for evaluation of candidate anti-Pneumocystis carinii agents.Pneumocystis mediates overexpression of antizyme inhibitor resulting in increased polyamine levels and apoptosis in alveolar macrophages.Polyamine transport as a target for treatment of Pneumocystis pneumonia.Pulmonary infectious complications of human immunodeficiency virus infection. Part II.Eflornithine for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: a preliminary review.Continuous infusion of DL-alpha-difluoromethylornithine and improved efficacy against a rat model of Pneumocystis carinii pneumoniaOrnithine decarboxylase in Pneumocystis carinii and implications for therapy.Alterations in cysteine proteinase content of rat lung associated with development of Pneumocystis carinii infection.
P2860
Q28316964-7F56E894-87FF-4453-AA3D-DC1F029D57AFQ28332765-37A345AF-6A3E-4F27-A894-1DB0B54712B0Q28343861-44F78E9E-2313-48D4-9867-A790674A6A0DQ28364140-A5FA5E0E-4FF4-45FA-A4F9-602B14F5BC8AQ28379210-8EB8D80B-9520-420A-A536-49AC12B0A5ECQ33313563-40650335-C9DF-44C6-BB57-46797C88726FQ35132441-0D1844A3-81CB-43A5-A408-0EDFAD1C299AQ37134470-EDA0B2A8-8377-4D5C-8464-A05919AF7B42Q37450672-0AEE2D8E-8197-4B65-9190-6150E507609DQ37929672-AFAF8DEB-4E5C-4D28-988A-A57E998BBD35Q38220831-B4566219-5528-40A4-B2CC-2C2B21114688Q39782931-A3B9C61C-2D68-45FD-B2F0-7977F1E0D6C5Q39867202-FEF67745-0BF2-4DEC-80C4-A49C4CB1A4B4Q40155580-7588D865-098F-4853-94D0-1906CB92E302
P2860
Efficacy of DL-alpha-difluoromethylornithine in a rat model of Pneumocystis carinii pneumonia
description
1988 nî lūn-bûn
@nan
1988 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Efficacy of DL-alpha-difluorom ...... Pneumocystis carinii pneumonia
@ast
Efficacy of DL-alpha-difluorom ...... Pneumocystis carinii pneumonia
@en
Efficacy of DL-alpha-difluorom ...... Pneumocystis carinii pneumonia
@nl
type
label
Efficacy of DL-alpha-difluorom ...... Pneumocystis carinii pneumonia
@ast
Efficacy of DL-alpha-difluorom ...... Pneumocystis carinii pneumonia
@en
Efficacy of DL-alpha-difluorom ...... Pneumocystis carinii pneumonia
@nl
prefLabel
Efficacy of DL-alpha-difluorom ...... Pneumocystis carinii pneumonia
@ast
Efficacy of DL-alpha-difluorom ...... Pneumocystis carinii pneumonia
@en
Efficacy of DL-alpha-difluorom ...... Pneumocystis carinii pneumonia
@nl
P2093
P2860
P356
P1476
Efficacy of DL-alpha-difluorom ...... Pneumocystis carinii pneumonia
@en
P2093
A B Clarkson
C Rosenberg
D E Williams
P2860
P304
P356
10.1128/AAC.32.8.1158
P407
P577
1988-08-01T00:00:00Z